Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 19935663 | HLA-C (HLA-C) | viremia | European | NA | NA | positive | |
| we show that the -35c allele is a proxy for high hla-c cell surface expression, and that individuals with high-expressing hla-c alleles progress more slowly to aids and control viremia significantly better than individuals with low hla-c expressing alleles. | |||||||
| 20463068 | HLA-C (HLA-C) | viremia | NA | NA | NA | negation | |
| in comparison, different levels of viremia in individuals with the common -35tt genotype were not associated with differences in nef function but with differences in hla-c mrna expression levels. | |||||||
| 20671542 | HLA-B*57 | viremia | NA | NA | NA | unclassified | |
| hiv-1 gag evolution in recently infected human leukocyte antigen-b*57 patients with low-level viremia. | |||||||
| 20671542 | HLA-B*57 | viremia | NA | NA | NA | positive+negation | |
| escape mutations in hla-b*57-restricted gag epitopes were present at study entry in all patients, but were not associated with significant increases in viremia. | |||||||
| 20671542 | HLA-B*57 | viremia | NA | NA | NA | positive+negation | |
| conversely, no new escape mutations in hla-b*57-restricted epitopes or known compensatory mutations were detected in patients who experienced significant increases in viremia. | |||||||
| 21124229 | HLA ASSOCIATED (HLA-ASSOCIATED) | viremia | NA | NA | NA | unclassified | |
| as observed previously for gag, hla-associated immune pressure in pol may contribute to viral attenuation and subsequent control of viremia. | |||||||
| 21305005 | HLA-DR (HLA-DR) | viremia | NA | NA | NA | unclassified | |
| to address these hypotheses, we measured frequencies of activated (cd38+ hla-dr+), regulatory (cd4+cd25+cd127(dim)), hiv-specific, and cmv-specific t cells among hiv controllers and 3 control populations: hiv-infected individuals with treatment-mediated viral suppression (art-suppressed), untreated hiv-infected "non-controllers" with high levels of viremia, and hiv-uninfected individuals. | |||||||
| 22883336 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | viremia | NA | NA | NA | unclassified | |
| when pairwise compared the results between the different transplant methods, significant differences of cmv viremia were found between human leukocyte antigen (hla) matched sibling and hla mismatched relatives, unrelative donor or cord blood (all p values < 0.05). | |||||||
| 23083418 | HLA MATCHED (HLA-MATCHED) | viremia | NA | NA | NA | unclassified | |
| bk virus viremia in a well-hla-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression. | |||||||
| 23133620 | HLA-DR (HLA-DR) | viremia | NA | prostaglandin | NA | unclassified | |
| we further demonstrate greater than one log(10) reduction in plasma viremia in the nonhuman primate system by loading of hep-atiii into anti-hla-dr immunoliposomes, which target tissue reservoirs of viral replication. | |||||||
Copyright 2024